Literature DB >> 19958619

[Efficacy of surgical resection of left and right transthoracic approaches for middle thoracic esophageal squamous cell carcinoma].

Kong-Jia Luo1, Jian-Hua Fu, Yi Hu, Tie-Hua Rong, Peng Lin, Xin Wang, Hong Yang, Bin Zheng, Yong-Feng Li.   

Abstract

BACKGROUND AND
OBJECTIVE: For squamous cell carcinoma of the middle thoracic esophagus, surgical resection of left or right transthoracic approach has its advantages and disadvantages, respectively. This study was to compare the outcomes between the two approaches.
METHODS: A total of 482 consecutive patients with middle thoracic esophageal squamous cell carcinoma (ESCC) underwent transthoracic esophagectomy between January 1999 and June 2005. These patients were divided into left transthoracic approach group (n=350) and right transthoracic approach group (n=132). Surgical resection rate, postoperative complications, lymphadenectomy, recurrence pattern, disease-free survival, and overall survival of the two groups were compared retrospectively.
RESULTS: The surgical resection rate was 92.0% in left approach group and 92.4% in right approach group (P=0.878). The incidence of postoperative complications was higher in right approach group than in left approach group (57.6% vs. 35.4%, P<0.001). The average number of lymph nodes resected was 11.8+/-6.6 in left approach group and 16.3+/-8.0 in right approach group (P<0.001). Lymphatic recurrence rate was lower in right approach group than in left approach group (51.1% vs. 69.6%,P=0.028), especially occurring to mediastinal lymph nodes (15.6% vs. 38.4%,P=0.005). Three-year disease-free survival was higher in right approach group than in left approach group(22.92+/-0.74 vs. 25.09+/-1.22, P=0.039).
CONCLUSION: Although left transthoracic resection reduced the incidence of postoperative complications, esophagectomy of right transthoracic approach was more effective in survival improvement.

Entities:  

Mesh:

Year:  2009        PMID: 19958619     DOI: 10.5732/cjc.008.10660

Source DB:  PubMed          Journal:  Ai Zheng


  5 in total

Review 1.  Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma.

Authors:  Yousheng Mao; Zhentao Yu; Bin You; Wentao Fang; Brian Badgwell; Mark F Berry; DuyKhanh P Ceppa; Chun Chen; Haiquan Chen; Miguel A Cuesta; Xavier Benoit D'Journo; Guy D Eslick; Jianhua Fu; Xiangning Fu; Shugeng Gao; Jianxing He; Jie He; Yunchao Huang; Gening Jiang; Zhongmin Jiang; Jae Y Kim; Danqing Li; Hui Li; Shanqing Li; Deruo Liu; Lunxu Liu; Yongyu Liu; Xiaofei Li; Yin Li; Weimin Mao; Daniela Molena; Christopher R Morse; Nuria M Novoa; Lijie Tan; Qunyou Tan; Alper Toker; Ti Tong; Qun Wang; Benny Weksler; Lin Xu; Shidong Xu; Tiansheng Yan; Lanjun Zhang; Xingyi Zhang; Xun Zhang; Zhu Zhang; Xiuyi Zhi; Qinghua Zhou
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

2.  Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy.

Authors:  Dan Su; Xinming Zhou; Qixun Chen; Youhua Jiang; Xun Yang; Weihui Zheng; Kaiyi Tao; Jie Wu; Zhen Yan; Liang Liu; Shaoyuan Wu; Weimin Mao
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

3.  Minimally invasive esophagectomy via Sweet approach in combination with cervical mediastinoscopy for esophageal squamous cell carcinoma: a case series.

Authors:  Wenxiang Wang; Baihua Zhang; Xu Li; Jie Wu; Zhining Wu; Yan Ding; Desong Yang; Jinming Tang; Min Su; Junliang Ma; Xianman You; Jianping Liang; Yong Zhou
Journal:  Int J Surg Oncol (N Y)       Date:  2017-11-08

4.  Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial (NST1501).

Authors:  You-Sheng Mao; Shu-Geng Gao; Yin Li; An-Lin Hao; Jun-Feng Liu; Xiao-Fei Li; Tie-Hua Rong; Jian-Hua Fu; Jian-Qun Ma; Mei-Qing Xu; Ren-Quan Zhang; Gao-Ming Xiao; Xiang-Ning Fu; Ke-Neng Chen; Wei-Min Mao; Yong-Yu Liu; Hong-Xu Liu; Zhi-Rong Zhang; Yan Fang; Dong-Hong Fu; Xu-Dong Wei; Li-Gong Yuan; Shan Muhammad; Wen-Qiang Wei; Philip Wai-Yan Chiu; Shane Lloyd; Francisco Schlottmann; Kenneth Meredith; Jose M Pimiento; Yi-Bo Gao; Jie He
Journal:  Ann Transl Med       Date:  2022-08

5.  Long-term survival of the middle and lower thoracic esophageal cancer patients after surgical treatment through left or right thoracic approach.

Authors:  Ding Yang; You-Sheng Mao; Jie He; Shu-Geng Gao; Ke-Lin Sun; Ju-Wei Mu; Qi Xue; Da-Li Wang; Yu-Shun Gao; Jun Zhao; Xiang-Yang Liu; De-Kang Fang; Jian Li; Yong-Gang Wang; Liang-Ze Zhang; Jin-Feng Huang; Bing Wang
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.